Ptc Therapeutics (PTCT) Capital Expenditures Growth (1y) (2013 - 2026)
Ptc Therapeutics (PTCT) Capital Expenditures Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ptc Therapeutics |
6.51 Bn |
4.61 Bn |
244.52 Mn |
-30.57% |
| Date | Value |
|---|
| Mar 31, 2026 |
-30.57% |
| Dec 31, 2025 |
189.08% |
| Sep 30, 2025 |
559.96% |
| Jun 30, 2025 |
117.86% |
| Mar 31, 2025 |
-82.02% |
| Dec 31, 2024 |
-147.88% |
| Sep 30, 2024 |
-97.71% |
| Jun 30, 2024 |
-92,287.50% |
| Mar 31, 2024 |
34,142.86% |
| Dec 31, 2023 |
-35.44% |
| Sep 30, 2023 |
324.30% |
| Jun 30, 2023 |
-99.91% |
| Mar 31, 2023 |
-99.70% |
| Dec 31, 2022 |
-1.19% |
| Sep 30, 2022 |
-7.91% |
| Jun 30, 2022 |
9.10% |
| Mar 31, 2022 |
64.26% |
| Dec 31, 2021 |
37.37% |
| Sep 30, 2021 |
76.66% |
| Jun 30, 2021 |
269.17% |
